Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression
1999

Prostate Cancer Factors Before and After Treatment

Sample size: 69 publication Evidence: moderate

Author Information

Author(s): Baretton G B, Klenk U, Diebold J, Schmeller N, Löhrs U

Primary Institution: Ludwig-Maximilians-University

Hypothesis

The study aims to understand the molecular mechanisms leading to androgen-independent growth in prostate cancer before and after androgen deprivation therapy.

Conclusion

The study found that p21/WAF1 overexpression before and after treatment is linked to a high proliferation rate and worse clinical outcomes in advanced prostate cancer.

Supporting Evidence

  • Before treatment, histologic grade was associated with Ki-67 index and PCD rate.
  • p21/WAF1 expression was the only significant prognostic factor for shorter survival.
  • After treatment, loss of AR expression was linked to high Ki-67 index.

Takeaway

Researchers looked at prostate cancer samples to see how treatment affects certain proteins, finding that a specific protein called p21/WAF1 can indicate how bad the cancer might be.

Methodology

Immunohistologic staining was performed on archival material from prostate cancer patients before and after androgen deprivation therapy.

Participant Demographics

69 prostate cancer patients, with some having untreated primary tumor samples for comparison.

Statistical Information

P-Value

p<0.002

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690390

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication